Ico-Hospital Duran I Reynals

Barcelona 08916

1 studies enrolling now · 6 studies all time

What they study most

Adult T Cell Leukemia/Lymphoma, Carcinoma, Pancreatic Ductal, Follicular Lymphoma (FL), Marginal Zone Lymphoma, Myelofibrosis, Non Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Relapsed/Refractory Peripheral T-Cell Lymphoma, Unsuspected Pulmonary Embolism

Studies at this site

• To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL — Recruiting now
• Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) — Running, not enrolling
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients — Completed